Global Laryngeal Cancer Therapeutics Market 2019-2023
SKU ID : TNV-14160389 | Publishing Date : 23-Apr-2019 | No. of pages : 121
Detailed TOC of Global Laryngeal Cancer Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Biologics - Market size and forecast 2018-2023
Small molecules - Market size and forecast 2018-2023
Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Bristol-Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Sanofi
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of vendors classification
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Global laryngeal cancer therapeutics market pipeline: Overview
Exhibit 18: Global laryngeal cancer therapeutics market pipeline: Snapshot
Exhibit 19: Type - Market share 2018-2023 (%)
Exhibit 20: Comparison by type
Exhibit 21: Biologics - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Biologics - Year-over-year growth 2019-2023 (%)
Exhibit 23: Small molecules - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Popular chemotherapies for treatment of laryngeal cancer
Exhibit 25: Small molecules - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by type
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2018-2023 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: North America - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in North America
Exhibit 33: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in Europe
Exhibit 36: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in Asia
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Top 3 countries in ROW
Exhibit 42: Key leading countries
Exhibit 43: Market opportunity
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 51: Bristol-Myers Squibb Co. - Product segments
Exhibit 52: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 53: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 54: Bristol-Myers Squibb Co. - Key offerings
Exhibit 55: Bristol-Myers Squibb Co. - Key customers
Exhibit 56: Eli Lilly and Co. - Vendor overview
Exhibit 57: Eli Lilly and Co. - Business segments
Exhibit 58: Eli Lilly and Co. - Organizational developments
Exhibit 59: Eli Lilly and Co. - Geographic focus
Exhibit 60: Eli Lilly and Co. - Segment focus
Exhibit 61: Eli Lilly and Co. - Key offerings
Exhibit 62: Eli Lilly and Co. - Key customers
Exhibit 63: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 69: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 70: Merck & Co. Inc. - Vendor overview
Exhibit 71: Merck & Co. Inc. - Business segments
Exhibit 72: Merck & Co. Inc. - Organizational developments
Exhibit 73: Merck & Co. Inc. - Geographic focus
Exhibit 74: Merck & Co. Inc. - Segment focus
Exhibit 75: Merck & Co. Inc. - Key offerings
Exhibit 76: Merck & Co. Inc. - Key customers
Exhibit 77: Sanofi - Vendor overview
Exhibit 78: Sanofi - Business segments
Exhibit 79: Sanofi - Organizational developments
Exhibit 80: Sanofi - Geographic focus
Exhibit 81: Sanofi - Segment focus
Exhibit 82: Sanofi - Key offerings
Exhibit 83: Sanofi - Key customers
Exhibit 84: Validation techniques employed for market sizing
Exhibit 85: Definition of vendors classification
Keyplayers in Global Laryngeal Cancer Therapeutics Market 2019-2023
Bristol-Myers Squibb Co.Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck & Co. Inc.
Sanofi